Mumbai A division bench of the Delhi High Court on Wednesday ordered Dr Reddy's Labs to file its reply to the injunction petition moved by Danish drug maker Novo Nordisk for its blockbuster weight-loss drug semaglutide, which is sold under the brand name Wegovy.
An expert in intellectual property laws told ET that the order may require Dr Reddy's Labs to explain the grounds for exports of weight-loss drug semaglutide.
The court's directive comes on the back of a plea by Novo Nordisk, which alleged patent infringement. The patent for the weight-loss drug is slated to end in March next year.
An expert in intellectual property laws told ET that the order may require Dr Reddy's Labs to explain the grounds for exports of weight-loss drug semaglutide.
The court's directive comes on the back of a plea by Novo Nordisk, which alleged patent infringement. The patent for the weight-loss drug is slated to end in March next year.
You may also like
185 Pakistani refugees granted Indian citizenship in Gujrat's Rajkot
Prince William will be joined by two key royals as he supports Lionesses on major trip
Jockey, 24, in hospital after horror fall saw air ambulance called to racecourse
Babar Azam left out of T20Is as Shaheen Afridi returns for Pakistan's West Indies tour
Emma Raducanu sheds light on new partner in crime as Brit eyes two trophies
